More articles from Review

  • Endocrinopathies from checkpoint inhibitors: Incidence, outcomes, and management
    Endocrinopathies from checkpoint inhibitors: Incidence, outcomes, and management
    CME article
    Randol Kennedy, MD, FACP, Hussein Awada, MD, Naga Vura, MD, Daniela Ciltea, MD and Michael Morocco, MD
    Cleveland Clinic Journal of Medicine May 2023, 90 (5) 307-317; DOI: https://doi.org/10.3949/ccjm.90a.22032

    A review of the incidence and severity of each immune checkpoint inhibitor-related endocrinopathy, factors related to toxicity risk, and principles of management.

  • Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome
    Sarah Khan, MD and Maureen Linganna, MD
    Cleveland Clinic Journal of Medicine April 2023, 90 (4) 209-213; DOI: https://doi.org/10.3949/ccjm.90a.22028

    A review of recommendations from the American Association for the Study of Liver Diseases.

  • Central sensitization, chronic pain, and other symptoms: Better understanding, better management
    Mary M. Volcheck, MSN, RN, Stephanie M. Graham, RN, Kevin C. Fleming, MD, Arya B. Mohabbat, MD and Connie A. Luedtke, RN, PMGT-BC
    Cleveland Clinic Journal of Medicine April 2023, 90 (4) 245-254; DOI: https://doi.org/10.3949/ccjm.90a.22019

    Clinicians have a pivotal role by providing patient education, which can affect perception, management, functional status, and quality of life.

  • Reproductive issues and multiple sclerosis: 20 questions
    Alise K. Carlson, MD, Daniel Ontaneda, MD, PhD, Mary R. Rensel, MD, Jeffrey A. Cohen, MD and Amy Kunchok, MD
    Cleveland Clinic Journal of Medicine April 2023, 90 (4) 235-243; DOI: https://doi.org/10.3949/ccjm.90a.22066

    The authors offer answers to frequently asked questions about the management of MS during pregnancy planning, pregnancy, and the postpartum period.

  • Smallpox and monkeypox: Looking back and looking ahead
    Paolo Sossai, MD, PhD, Domenico Staiti, MD, Massimiliano Cannas, MD and Piero Grima, MD
    Cleveland Clinic Journal of Medicine March 2023, 90 (3) 141-144; DOI: https://doi.org/10.3949/ccjm.90a.22067

    Two vaccines have been developed for mpox prevention, but clarity is needed on when and how to use them.

  • To repeat or not to repeat? Measuring bone mineral density during anti-resorptive therapy or a drug holiday
    Tayyab S. Khan, MD, Partha Sinha, MD, PhD and Harold Rosen, MD
    Cleveland Clinic Journal of Medicine March 2023, 90 (3) 173-180; DOI: https://doi.org/10.3949/ccjm.90a.22071

    The authors present evidence for and against monitoring bone mineral density in these patients, arguing against a one-size-fits-all approach.

  • Colovesical fistula in men with chronic urinary tract infection: A diagnostic challenge
    Risheng Xu, DO, Austin Vaughan, DO, Mitchell Fagan, DO, Dylan P. Schumacher, MD, Verra Wekullo, MD and Bruce Gehrke, MD
    Cleveland Clinic Journal of Medicine March 2023, 90 (3) 165-171; DOI: https://doi.org/10.3949/ccjm.90a.21060

    Most cases are in older men with diverticular disease, Crohn disease, cancer, or iatrogenic injury. Suspect it especially in these patients with UTI symptoms refractory to conventional treatments.

  • Resistant hypertension: A stepwise approach
    Resistant hypertension: A stepwise approach
    CME article
    Jordana Yahr, DO, George Thomas, MD, Juan Calle, MD and Jonathan J. Taliercio, DO
    Cleveland Clinic Journal of Medicine February 2023, 90 (2) 115-125; DOI: https://doi.org/10.3949/ccjm.90a.22046

    The authors review the definition and prevalence of resistant hypertension and its diagnostic workup and management, including lifestyle modifications, drugs, and experimental therapies.

  • Myasthenia gravis: Frequently asked questions
    John A. Morren, MD and Yuebing Li, MD, PhD
    Cleveland Clinic Journal of Medicine February 2023, 90 (2) 103-113; DOI: https://doi.org/10.3949/ccjm.90a.22017

    Who is at risk? Which tests should be ordered? How does the disease course affect management decisions? What instructions should you give patients? And other questions.

  • Bone turnover markers to monitor oral bisphosphonate therapy
    CME article
    Nikita Ashcherkin, MD, Archna A. Patel, MD, MPH, Alicia Algeciras-Schimnich, PhD and Krupa B. Doshi, MD, FACE
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 26-31; DOI: https://doi.org/10.3949/ccjm.90a.22002

    Rapid changes in levels of bone turnover markers can be useful in monitoring the effectiveness of therapy and improving adherence to therapy.

Pages

Pages